About Us

May 16, 2016

IntegriChain Strengthens Operations Leadership Team to Maximize Customer Value from Life Sciences Channel Data Aggregation, Applications, and Analytics Offerings

Deep Trade and Pharma Expertise and Operations Expansion to Improve Customer Efficiencies in Delivering Products to Patients

Philadelphia, PA, May 16, 2016IntegriChain, a rapidly growing healthcare technology company focused on channel management for life sciences suppliers, today announced the appointment of industry veteran Melissa O’Neal as Senior Director of Customer Operations. O’Neal’s appointment is part of a significant expansion and realignment in IntegriChain’s Operations team to heighten process improvement that maximizes customer value of the company’s data aggregation, applications, and analytics for life sciences manufacturers.

“IntegriChain has grown rapidly during the last several years, and we are committed to building a world-class team so that we can continue to serve our innovative customers and ultimately help them improve the patient journey for their products,” said Kevin Leininger, co-founder and CEO of IntegriChain. “Melissa’s appointment to our senior leadership team, along with the customer-centric evolution of our Operations team, elevates the quality of our product and service delivery and positions IntegriChain as a leader in healthcare technology for our next stage of growth.”

O’Neal spent the last year as Managing Partner of 12th Union Group, a boutique consulting firm. Prior to her consulting experience, she spent more than four years in leadership of Operations, Trade Services, and Analytics at Galderma, a global leader in medical solutions for skin health. Previously, she served 12 years at UPS in various Marketing and Data Services leadership roles. In her new Customer Operations role at IntegriChain, O’Neal will oversee all inbound and outbound customer communications and tracking, application support and administration, usage planning and Customer Success Management execution, quarterly business reviews, data investigations, and Level I and II support.

“Melissa offers IntegriChain invaluable insight from the life sciences supplier point of view, ensuring our support organization understands our customers’ businesses and their objectives for using our services,” said Brad Burget, Vice President of Operations. “Her deep experience within Trade and pharma boosts the industry expertise of the IntegriChain team beyond our sales and marketing staff and into our Operations function, where this subject matter knowledge can help coach our customers to success.”

In addition to this appointment, IntegriChain expanded and realigned its Operations, comprising the new Customer Operations team under O’Neal’s leadership, a new Data Factory Operations team, Data Pipeline Operations, Project Management Operations, and Professional Services. The newly formed Data Factory Operations team will focus on process improvement and is responsible for all aspects of IntegriChain’s day- to-day data monitoring and administration, overseeing and approving all factory changes, Master Data Management, base data (852, 867, EXF, 844, 849, and 180) production and QA, and enriched data data production and QA.

Data Pipeline Operations is responsible for IntegriChain’s existing data pipeline as well as its infrastructure innovation strategy to scale and support the data volumes necessary to continue to evolve the IntegriChain healthcare channel management platform, allowing healthcare manufacturers to efficiently utilize large and diverse data sets to gain business insight from the channel. The Project Management Operations team will continue to lead customer and product onboarding and internal and external project management. Professional Services and Advanced Analytics will lead custom report development and a growing array of professional services offerings as well as IntegriChain Inventory Retail enriched data offering and benchmark and returns analog data.

About IntegriChain
IntegriChain is a rapidly growing healthcare technology company, offering the leading channel management cloud used by life sciences suppliers, including nine of the top-10 pharmaceutical manufacturers, to drive channel collaboration and to improve the efficiency of how products reach customers. Pharmaceutical, biopharm/specialty pharma, generics, and consumer health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. As a suite of informed applications and analytics built on top of aggregated channel inventory and point-of-sale (POS) data, IntegriChain provides customer operations, national accounts, and finance teams with a collaborative, agile, and mobile alternative to ERP and homegrown systems. By embedding big-data customer insights into daily business processes, IntegriChain helps control the high cost of product distribution while improving product availability, ensuring a higher level of revenue predictability and maximizing distribution investment. More than $200 billion in annual US commerce and two billion transactions flow through the IntegriChain Cloud annually. IntegriChain is backed by Accel-KKR, a leading technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.

IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.

Contact
Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com